| Literature DB >> 1426186 |
Abstract
Keywords: Americas; Biology; Carbohydrate Metabolic Effects; Cardiovascular Effects; Clinical Research; Clinical Trials; Contraception; Contraception Failure; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods; Contraceptive Usage; Desogestrel; Developed Countries; Economic Factors; Europe; Family Planning; Gestodene; Glucose Metabolism Effects; Government Agencies; Levonorgestrel; Lipid Metabolic Effects; Lipids; Litigation; Marketing; Metabolic Effects; Norethindrone; Norgestimate; North America; Northern America; Oral Contraceptives; Oral Contraceptives, Combined; Organizations; Physiology; Research Methodology; Risk Factors; United States; Western Europe
Mesh：
Substances：
Year: 1992 PMID： 1426186
Source DB: PubMed Journal: Fam Plann Perspect ISSN： 0014-7354